Semperit Aktiengesellschaft Holding (WBAG:SEM) has decided to delay the selling of its medical business Sempermed, which includes Latexx Partners Bhd. When contacted by The Edge, a Semperit spokesperson explained that the group, had in January 2020 decided to separate Sempermed. However, the Covid-19 crisis has set new priorities for the group, the spokesperson says. In the current phase, the focus is on supply security for Austria. Semperit is fulfilling its responsibility to Austria and supporting the republic with its medical gloves in order to make the greatest possible contribution to combating the coronavirus crisis. For these reasons, the implementation of the strategic landmark decision to separate from the medical business will be delayed in any case. “Short-term demand cycles do not change the basis for this fundamental strategic decision. But if the strategic landmark decision changes, we will inform the public accordingly”, the spokesperson says. However, she declined to comment on whether the group has sourced a buyer yet or on the disposal price for Latexx Partners.